Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH

Acta Oncologica

Volumn 48, Issue 3, 2009, Pages 452-456

  Muecke, Ralph ^a,g   Klotz, Theodor ^b   Giedl, Josef ^b   Buentzel, Jens ^c,g   Kundt, Guenther ^d   Kisters, Klaus ^e,g   Prott, Franz Josef ^a   Micke, Oliver ^f,g  

^a ST JOSEFS HOSPITAL   (Germany)

^b Municipal Hospital   (Germany)

^c Department of Otolaryngology   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e ST ANNA HOSPITAL   (Germany)

^f FRANZISKUS HOSPITAL   (Germany)

^g German Working Group Trace Elements and Electrolytes in Oncology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRAPHITE; PROSTATE SPECIFIC ANTIGEN; SELENIUM; TUMOR MARKER;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; AUTOMATION; BLOOD; BLOOD LEVEL; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MALE; NORMAL VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE HYPERTROPHY; TISSUE LEVEL; BLOOD ANALYSIS; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; PROSTATE; PROSTATE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SELENIUM; SPECTROPHOTOMETRY, ATOMIC; TUMOR MARKERS, BIOLOGICAL;

EID: 65349157725     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802403721     Document Type: Article

References (53)

1. Buentzel J, Glatzel M, Kisters K, Muecke R, Schoenekaes K, Micke O. Selenium as radioprotector in head and neck cancer patients- first clinical results. Trace Elem Electrolytes 2006;/23:/178-80.
2. Buentzel J, Glatzel M, Muecke R, Bruns F, Kisters K, Micke O. Scavenging of free radicals and late toxicity of radiochemotherapy in head and neck cancer patients. Trace Elem Electrolytes 2006;/23:/181-85.
3. Buentzel J, Micke O, Glatzel M, Froehlich D, Bruns F, Muecke R, et al. Serum selenium in head and neck cancer patients- a new marker of tumor activity? Anticancer Res 2005;/25:/1711-2.
4. Funke AM. Potential of selenium in gynecological oncology. Med Klin 1999;/94:/42-4.
5. Knekt P, Aromaa A, Mantela J. Serum selenium and subsequent risk of cancer among Finnish men and woman. J Natl Cancer Inst 1990;/82:/864-8.
6. Micke O, Buentzel J, Bruns F, et al. Selenium in oncology- Past, presence and future. Trace Elem Electrolytes 2006;/22:/ 66.
7. Muecke R, Micke O, Schoenekaes KG. Serum selenium levels, glutathione peroxidase activities and serum redox potential levels in patients with untreated non-small cell lung cancer and adenocarcinoma of the rectum. Trace Elem Electrolytes 2000;/17:/119-23.
8. Muecke R, Glatzel M, Reichl B, Bernd-Skorka R, Buentzel J, Bruns F, et al. Sodium selenite in gynecologic radiation oncology- results of a prospective randomized observation study. Trace Elem Electrolytes 2006;/23:/173-7.
9. Pawlowicz Z, Zachara BA, Trafikowska U, Maciag A, Marchaluk E, Nowicki A. Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer. J Trace Elem Electrolytes Health Dis 1991;/5:/272-7.
10. Pawlowicz Z, Zachara BA, Trafikowska U, Nowicki A. Low levels of selenium and activity of glutathione peroxidase in blood of patients with gastrointestinal neoplasma. Pol Tyg Lek 1993;/48:/554-6.
11. Rayman MP. The importance of selenium to human health. Lancet 2000;/356:/233-41.
12. Torun M, Aldemir H, Yardim S. Serum selenium levels in various cancer types. Trace Elem Electrolytes 1995;/12:/186-90.
13. Turan B, Delilbasi E. The serum selenium and immunoglobulin levels in healthy and cancer cases. J Biochem 1992;/17:/ 29-36.
14. Brinkmann M, Reulen RC, Kellen E, Buntinx F, Zeegers MP. Are men with low selenium levels at increased risk of prostate cancer. Eur J Cancer 2006;/42:/2463-71.
15. Brooks JD, Metter EJ, Chan DW. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urolog 2001;/166:/2034-8.
16. Li H, Stampfer MJ, Giovannuvcci EL, Morris JS, Willet WC, Gaziano JM, et al. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 2004;/96:/696-703.
17. Ozmen H, Erulas FA, Karatas F, Cukurovali A, Yalcin O. Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer. Clin Chem Lab Med 2006;/44:/175-9.
18. Zachara BA, Szewczyk-Golec K, Tyloch J, Wolski Z, Szylberg T, Stepien S, et al. Blood and tissue selenium concentration and glutathione peroxidase activities in patients with prostate cancer and benign prostate hyperplasia. Neoplasma 2005;/52:/248-54.
19. Brawley OW, Parnes H. Prostate cancer prevention trials in the USA. Eur J Cancer 2000;/36:/1312-5.
20. Chan JM, Stampfer MJ, Giovannucci EL. What causes prostate cancer. A brief summary of the epidemiology. Semin Cancer Biol 1998;/8:/263-73.
21. Giovannucci EL, Clinto SK. Tomatoes, lycopene, and prostate cancer. Proc Soc Exp Biol Med 1998;/218:/129-39.
22. Giovannucci EL. Selenium and risk of prostate cancer. Lancet 1998;/352:/755-6.
23. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;/276:/1957-63.
24. Clark LC, Dalkin B, Krongrad A, Combs GF, Turnbull BW, Slate EH, et al. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 1998;/81:/730-4. (Pubitemid 28316638)
25. Lowe JF, Frazee LA. Update on prostate cancer chemoprevention. Pharmacotherapy 2006;/26:/353-9.
26. Klein EA. Selenium and vitamin E cancer prevention trial. Ann NY Acad Sci 2004;/1031:/234-41.
27. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson JM, Kristal AR, et al. Designing the selenium and vitamin E cancer prevention trial (SELECT). J Natl Cancer Inst 2005;/97:/94-102.
28. Gianduzzo TR, Holmes EG, Tinggi U, Shahin M, Mactaggart P, Nicol D. Prostatic and peripheral blood selenium levels after oral supplementation. J Urol 2003;/170:/870-3.
29. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, et al. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of 1-selenomethionine: A Southwest Oncology Group Study. Clin Cancer Res 2006;/12:/2178-84.
30. Zachara BA, Szewczyk-Golec K,Wolski Z, Tyloch J, Skok Z, Bloch-Boguslawska E, et al. Selenium level in benign and cancerous prostate. Biol Trace Elem Res 2005;/103:/199-206.
31. Winnefeld K, Dawczynski H, Schirrmeister W, Adam G, Friedrich U, Hein S. Selenium in serum and whole blood in patients with surgical interventions. Biol Trace Elem Res 1995;/50:/149-55.
32. Thompson HJ, Wilson A, Lu J, Singh M, Jiang C, Upadhyaya P, et al. Comparison of the effects of an organic and inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 1994;/15:/183-6.
33. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998;/7:/531.
34. Ketterer B, Meyer DJ. Glutathione transferases: A possible role in the detoxication and repair of DNA and lipid hydroperoxides. Mutat Res 1989;/214:/33.
35. Lee W, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, et al. Cytidine methylation of regulatory sequences near the pi-class glutathione-S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994;/91:/11733.
36. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenisis 1999;/20:/1675.
37. Menter DG, Sabichi AL, Lippman SM. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev 2000;/9:/1171-82.
38. Giovannucci EL. Selenium and risk of prostate cancer. Lancet 1998;/352:/755-6.
39. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;/276:/1957-63.
40. Clark LC, Dalkin B, Krongrad A, Combs GF, Turnbull BW, Slate EH, et al. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 1998;/81:/730-4. (Pubitemid 28316638)
41. Lowe JF, Frazee LA. Update on prostate cancer chemoprevention. Pharmacotherapy 2006;/26:/353-9.
42. Klein EA. Selenium and vitamin E cancer prevention trial. Ann NY Acad Sci 2004;/1031:/234-41.
43. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson JM, Kristal AR, et al. Designing the selenium and vitamin E cancer prevention trial (SELECT). J Natl Cancer Inst 2005;/97:/94-102.
44. Gianduzzo TR, Holmes EG, Tinggi U, Shahin M, Mactaggart P, Nicol D. Prostatic and peripheral blood selenium levels after oral supplementation. J Urol 2003;/170:/870-3.
45. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, et al. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of 1-selenomethionine: A Southwest Oncology Group Study. Clin Cancer Res 2006;/12:/2178-84.
46. Zachara BA, Szewczyk-Golec K,Wolski Z, Tyloch J, Skok Z, Bloch-Boguslawska E, et al. Selenium level in benign and cancerous prostate. Biol Trace Elem Res 2005;/103:/199-206.
47. Winnefeld K, Dawczynski H, Schirrmeister W, Adam G, Friedrich U, Hein S. Selenium in serum and whole blood in patients with surgical interventions. Biol Trace Elem Res 1995;/50:/149-55.
48. Thompson HJ, Wilson A, Lu J, Singh M, Jiang C, Upadhyaya P, et al. Comparison of the effects of an organic and inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 1994;/15:/183-6.
49. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998;/7:/531.
50. Ketterer B, Meyer DJ. Glutathione transferases: A possible role in the detoxication and repair of DNA and lipid hydroperoxides. Mutat Res 1989;/214:/33.
51. Lee W, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, et al. Cytidine methylation of regulatory sequences near the pi-class glutathione-S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994;/91:/11733.
52. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenisis 1999;/20:/1675.
53. Menter DG, Sabichi AL, Lippman SM. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev 2000;/9:/1171-82.